Home » Topics » BioWorld Science

BioWorld Science
RSS

Na+/K+-ATPase inhibitors revealed by Sigma-Tau

July 12, 1996

Icos granted U.S. patent for rPAF-AH

July 12, 1996

Torii and Hisamitsu disclose elastase inhibitors

July 12, 1996

APC-366 covered under U.S. patent

July 12, 1996

WAY-126120: Selective PDE IV inhibitor

July 12, 1996

Novel 5-lipoxygenase inhibitors described by Pfizer

July 12, 1996

NOS inhibitors from Merck & Co.

July 12, 1996

TNF research findings

July 12, 1996

Muscarinic receptor ligand selected for further study

July 12, 1996

First demonstration of cellular mechanism of human oral tolerance

July 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...